Nirupama Yechoor

Nirupama Yechoor

Auto-generated profile, based on publicly available information

Nirupama Yechoor

Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in Neurology
Verified
Journal Article
Closed access
SMSandro Marini
Sandro Marini
TKTamara N. Kimball
Tamara N. Kimball
EMErnst Mayerhofer
Ernst Mayerhofer
RTReinier W.P. Tack
Reinier W.P. Tack
JSJasper R. Senff
Jasper R. Senff
CAChristopher D. Anderson
Christopher D. Anderson
The 21-point Brain Care Score (BCS) is an index that ranks behaviors and clinical measurements with the aim of encouraging lifestyle adjustments to lower the incidence of age-related brain disease, including stroke, late-life depression (LLD), and dementia. A higher BCS at baseline is associated with a lower risk of these outcomes. We aimed to investigate whether the associations between BCS and stroke, LLD, and dementia risks are independent of genetic predisposition for these conditions and quantify the effect of healthy lifestyle across genetic risk distributions for these outcomes. Using the UK Biobank (UKB) prospective cohort study, we computed baseline BCSs and polygenic scores to estimate genetic predisposition for stroke and LLD and APOE ε allele status to stratify dementia risk. As for outcomes again in UKB, we measured incidence of stroke, LLD, and dementia. We used multivariate Cox proportional hazard models to assess associations between BCS, genetic predisposition, and these outcomes. We also conducted stratified and interaction analyses to estimate the incidence of these outcomes across quartiles of genetic risk and BCS. We included 368,340 UKB participants (median age 58 years (interquartile range 51-63 years), 46.3% male). Independent of genetic risk, a 5-point increase in BCS corresponded to lowered hazards of stroke (hazard ratio [HR] 0.70, 95% CI 0.68-0.73), LLD (HR 0.65, 95% CI 0.63-0.67), and dementia (HR 0.82, 95% CI 0.78-0.85). Incidences of all 3 outcomes were higher among participants with high genetic risk of these outcomes. However, these increased risks were offset for individuals with a higher BCS (incidence rates per 1,000 person-years were 2.76 vs 1.19 for stroke, 7.34 vs 4.46 for LLD, and 3.64 vs 2.05 for dementia, when comparing low and high BCS). Across different genetic predispositions for stroke, LLD, and dementia, healthier lifestyle behaviors are protective for brain health, demonstrating the nondeterminism of genetic risk. Furthermore, differences in BCS behave as aggregate risk estimators of all 3 outcomes. Further work is needed to prospectively investigate the utility and performance of the BCS as a targeted intervention in populations at elevated genetic risk of age-related brain disease.

27 August 2024 in Neurology
Verified
Journal Article
Closed access
CRCyprien A. Rivier
Cyprien A. Rivier
SSSanjula Singh
Sanjula Singh
JSJasper Senff
Jasper Senff
RTReinier W. Tack
Reinier W. Tack
SMSandro Marini
Sandro Marini
GFGuido J. Falcone
Guido J. Falcone
To investigate associations between health-related behaviors as measured using the Brain Care Score (BCS) and neuroimaging markers of white matter injury. This prospective cohort study in the UK Biobank assessed the BCS, a novel tool designed to empower patients to address 12 dementia and stroke risk factors. The BCS ranges from 0 to 21, with higher scores suggesting better brain care. Outcomes included white matter hyperintensities (WMH) volume, fractional anisotropy (FA), and mean diffusivity (MD) obtained during 2 imaging assessments, as well as their progression between assessments, using multivariable linear regression adjusted for age and sex. We included 34,509 participants (average age 55 years, 53% female) with no stroke or dementia history. At first and repeat imaging assessments, every 5-point increase in baseline BCS was linked to significantly lower WMH volumes (25% 95% CI [23%-27%] first, 33% [27%-39%] repeat) and higher FA (18% [16%-20%] first, 22% [15%-28%] repeat), with a decrease in MD (9% [7%-11%] first, 10% [4%-16%] repeat). In addition, a higher baseline BCS was associated with a 10% [3%-17%] reduction in WMH progression and FA decline over time. This study extends the impact of the BCS to neuroimaging markers of clinically silent cerebrovascular disease. Our results suggest that improving one's BCS could be a valuable intervention to prevent early brain health decline.

1 May 2024 in Stroke
Verified
Journal Article
Open access
PDF file
JSJasper R. Senff
Jasper R. Senff
SSSanjula D. Singh
Sanjula D. Singh
MPMarco Pasi
Marco Pasi
WJWilmar M.T. Jolink
Wilmar M.T. Jolink
MRMark A. Rodrigues
Mark A. Rodrigues
HBH. BART BROUWERS
H. BART BROUWERS
BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) in the cerebellum has a poor short-term prognosis, whereas data on the long-term case fatality and recurrent vascular events are sparse. Herewith, we aimed to assess the long-term case fatality and recurrence rate of vascular events after a first cerebellar ICH. METHODS: In this international cohort study, we included patients from 10 hospitals (the United States and Europe from 1997 to 2017) aged ≥18 years with a first spontaneous cerebellar ICH who were discharged alive. Data on long-term case fatality and recurrence of vascular events (recurrent ICH [supratentoria or infratentorial], ischemic stroke, myocardial infarction, or major vascular surgery) were collected for survival analysis and absolute event rate calculation. RESULTS: We included 405 patients with cerebellar ICH (mean age [SD], 72 [13] years, 49% female). The median survival time was 67 months (interquartile range, 23–100 months), with a cumulative survival rate of 34% at 10-year follow-up (median follow-up time per center ranged: 15–80 months). In the 347 patients with data on vascular events 92 events occurred in 78 patients, after initial cerebellar ICH: 31 (8.9%) patients had a recurrent ICH (absolute event rate, 1.8 per 100 patient-years [95% CI, 1.2–2.6]), 39 (11%) had an ischemic stroke (absolute event rate, 2.3 [95% CI, 1.6–3.2]), 13 (3.7%) had a myocardial infarction (absolute event rate, 0.8 [95% CI, 0.4–1.3]), and 5 (1.4%) underwent major vascular surgery (absolute event rate, 0.3 [95% CI, 0.1–0.7]). The median time to a first vascular event during follow-up was 27 months (interquartile range, 8.7–50 months), with a cumulative hazard of 47% at 10 years. CONCLUSIONS: The long-term prognosis of patients who survive a first spontaneous cerebellar ICH is poor and comparable to that of patients who survive a first supratentorial ICH. Further identification of patients at high risk of vascular events following the initial cerebellar ICH is needed. Including patients with cerebellar ICH in randomized controlled trials on secondary prevention of patients with ICH is warranted.

4 July 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
LPLivia Parodi
Livia Parodi
EMErnst Mayerhofer
Ernst Mayerhofer
KNKaavya Narasimhalu
Kaavya Narasimhalu
NYNirupama Yechoor
Nirupama Yechoor
MCMary E. Comeau
Mary E. Comeau
CAChristopher D. Anderson
Christopher D. Anderson
Cerebral small vessel disease is highly prevalent, particularly in marginalized communities, and its incidence is expected to increase given the aging global population. Cerebral small vessel disease contributes to risk for stroke, vascular cognitive impairment and dementia, late‐life depression, and gait disorders. A growing body of evidence suggests that adverse outcomes, including cerebral small vessel disease, caused by traditional cardiovascular risk factors are at least partly mediated by epigenetic changes, some of them already beginning during fetal development. Societal and health care access inequities, summarized under the umbrella term social determinants of health, put a higher burden of cardiovascular risk factors on marginalized populations and expose them to an increased risk for adverse outcomes. Social epigenetics has begun to deliver solid evidence that social determinants of health lead to distinct epigenetic signatures that potentially mediate the biological effect of environmental exposures on cardiovascular risk factors. Here, we provide a review of the most recent advances in the epigenetics of cerebral small vessel disease risk factors and social determinants of health and call for research efforts combining insights from both fields to reach a deeper understanding of the causal pathways, ultimately facilitating discovery of new treatment targets for a disease whose burden is magnified by existing health disparities.

1 October 2025 in JAMA Network Open
Verified
Journal Article
Open access
DCDevanshi Choksi
Devanshi Choksi
MCMary Craven
Mary Craven
TMTaylor McVeigh
Taylor McVeigh
AMAkashleena Mallick
Akashleena Mallick
TRTanzeela Ranman
Tanzeela Ranman
NYNirupama Yechoor
Nirupama Yechoor
Importance: Physical, behavioral, and social outcomes after stroke are determined by the complex interaction of external states (eg, mobility) and internal states (eg, emotional distress). Improving these outcomes, collectively called health-related quality of life (HRQOL), requires their accurate measurement.Objectives: To identify important HRQOL constructs that are associated with poststroke recovery and assess whether the Stroke-Specific Quality of Life (SSQOL) Scale, which measures 12 physical and psychosocial outcomes, adequately captures HRQOL for survivors of stroke.Design, Setting, and Participants: This qualitative study was conducted between October 1, 2023, and December 31, 2024, at 2 US comprehensive stroke centers. Stroke survivors and caregivers participated in 2 consecutive focus group sessions: the first on physical well-being and the second on emotional well-being. All stroke survivors completed the SSQOL survey.Exposures: Physical and emotional well-being in recovery after stroke.Main Outcomes and Measures: Identification of themes regarding HRQOL constructs and their coherence with the SSQOL Scale. The framework method was used for qualitative analysis, and joint displays were used to assess coherence between qualitative themes and SSQOL Scale domains.Results: A total of 41 participants (median age, 55 years [range, 27-77 years]; 22 women [54%]) were recruited nationally; the cohort comprised 30 stroke survivors and 11 caregivers. Qualitative analysis demonstrated 5 key HRQOL constructs crucial to physical and emotional well-being in recovery. Reduced physical functioning and reduced social participation were key external states associated with recovery. Loss of independence, feelings of shame, and the fear of uncertainty were key internal states associated with HRQOL. This analysis confirms that the SSQOL Scale adequately captures the external states associated with HRQOL (reduced physical functioning and reduced social participation). However, internal states were only partially captured by SSQOL Scale.Conclusion and Relevance: This qualitative study of lived experiences among stroke survivors and caregivers suggested that internal states shape recovery but were not fully captured in a validated, widely used HRQOL assessment, highlighting a potential gap that may be unaddressed in routine poststroke care. Future studies are required to understand which combination of validated assessments may provide more comprehensive assessments of HRQOL during poststroke recovery.

10 June 2025 in Neurology
Verified
Journal Article
Closed access
DCDevanshi Choksi
Devanshi Choksi
LGLeidys Gutiérrez-Martínez
Leidys Gutiérrez-Martínez
PRPamela M. Rist
Pamela M. Rist
JBJulie E. Buring
Julie E. Buring
JSJasper R. Senff
Jasper R. Senff
NYNirupama Yechoor
Nirupama Yechoor
In the United States, stroke is the third leading cause of death among women, with 1 in 5 women aged 55 to 75 years expected to experience a stroke. The Brain Care Score (BCS) is an evidence-based tool designed to motivate lifestyle changes, with higher scores associated with reduced risk of stroke, dementia, and depression. We aim to measure the association of the BCS and incident cerebrovascular events (CVEs), including stroke and transient ischemic attack (TIA), in the Women's Health Study (WHS). The WHS comprises women health professionals aged 45 and older in the United States. Participants without history of CVE and complete data available to calculate a BCS and covariates 5 years after enrollment were included. Higher BCS reflects better risk factor control, with the minimum score being 0 and the maximum score being 20. Cox proportional hazard models examined the association between BCS and incident CVE adjusted for potential confounders. A total of 21,271 women were eligible with a median age of 57.9 years (interquartile range: 53.9-63.8) and median BCS of 15 (interquartile range [IQR]:13-16). There were 1,294 incident CVE cases (6.1%) during a median follow-up of 22.4 (IQR: 15.9-23.5) years. A five-point higher baseline BCS was associated with a 37% decrease in the risk of incident CVE after adjusting for age, menopausal status, use of hormonal replacement therapy, and other known cardiovascular disease risk factors (hazard ratio [HR] 0.63, 95% CI 0.56-0.71). This association remained significant after adjusting for race, educational attainment, and income (HR 0.64, 95% CI 0.57-0.72). There was a 28% decreased risk of incident CVE among those with a BCS equal to or above the median compared with those with a BCS below the median, in a fully adjusted model (HR 0.72, 95% CI 0.64-0.80). Higher baseline BCS was associated with a decreased risk of incident CVE in the WHS. Future studies are needed to study the BCS in more diverse populations and to investigate how changes in BCS across the lifespan affect risk of CVE.